SEC Form 4 · accession 0001185185-15-001011
Entia Biosciences, Inc. · ERGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Devin D. Andres
Officer — Chief Operating Officer
Period of report
Apr 24, 2015
Accepted (ET)
Apr 28, 2015 · 11:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001408299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 24, 2015 | A | 550,000 | $0.20 | A | 1,171,671 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The shares of common stock were issued to Mr. Andres in payment of bonus.